Jan G.M. Klijn

29.3k citations

148 papers · 16.8k indexed · 7 hit papers · h-index 62

Molecular Biology top 0.5%
Oncology top 0.2%
Cancer Research top 0.1%
Genetics top 0.1%
Pathology and Forensic Medicine top 0.5%

Co-authors: John A. Foekens Anieta M. Sieuwerts Maxime P. Look Els M.J.J. Berns Yixin Wang Marion E. Meijer‐van Gelder Jack X. Yu Yi Zhang
Topics: BRCA gene mutations in cancer (56 papers)Breast Cancer Treatment Studies (23 papers)Cancer Genomics and Diagnostics (19 papers)
Cited by: Cancer Research Oncology Genetics
Journals: New England Journal of Medicine Proceedings of the National Academy of Sciences The Lancet
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Jan G.M. Klijn

146 papers receiving 16.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

2005 2.1k citations Yixin Wang, Jan G.M. Klijn et al. profile →
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition

2004 1.2k citations Mieke Kriege, Cecile T.M. Brekelmans et al. New England Journal of Medicine profile →
Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series

2007 726 citations Yixin Wang, Jan G.M. Klijn et al. Clinical Cancer Research profile →
Breast Cancer after Prophylactic Bilateral Mastectomy in Women with aBRCA1orBRCA2Mutation

2001 658 citations Bert van Geel, Sonja C. Henzen‐Logmans et al. New England Journal of Medicine profile →
Long-Term Risk of Cardiovascular Disease in 10-Year Survivors of Breast Cancer

2007 626 citations Maartje J. Hooning, Berthe M.P. Aleman et al. profile →
Subtypes of Breast Cancer Show Preferential Site of Relapse

2008 622 citations Marcel Smid, Yixin Wang et al. Cancer Research profile →
Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor–Positive Breast Carcinomas Through Genomic Grade

2007 599 citations John A. Foekens, Jan G.M. Klijn et al. profile →

Peers

Countries citing papers authored by Jan G.M. Klijn

Since Specialization

Citations

This map shows the geographic impact of Jan G.M. Klijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan G.M. Klijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan G.M. Klijn more than expected).

Fields of papers citing papers by Jan G.M. Klijn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan G.M. Klijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan G.M. Klijn. The network helps show where Jan G.M. Klijn may publish in the future.

Co-authorship network of co-authors of Jan G.M. Klijn

This figure shows the co-authorship network connecting the top 25 collaborators of Jan G.M. Klijn. A scholar is included among the top collaborators of Jan G.M. Klijn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan G.M. Klijn. Jan G.M. Klijn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer 2013 ·Breast Cancer Research and Treatment ·Antoinette Hollestelle,Justine Peeters,Marcel Smid,Mieke Timmermans,Leon C. Verhoog,Pieter J. Westenend,Anouk A. J. Heine,Alan Chan,Anieta M. Sieuwerts,Erik A.C. Wiemer,Jan G.M. Klijn,Peter J. van der Spek,John A. Foekens,Mieke Schutte,Michael A. den Bakker,John W.M. Martens	103
2	Copy Number Alterations that Predict Metastatic Capability of Human Breast Cancer 2009 ·Cancer Research ·Yi Zhang,John W.M. Martens,Jack X. Yu,John Jiang,Anieta M. Sieuwerts,Marcel Smid,Jan G.M. Klijn,Yixin Wang,John A. Foekens	70
3	Association of an Extracellular Matrix Gene Cluster with Breast Cancer Prognosis and Endocrine Therapy Response 2008 ·Clinical Cancer Research ·Jozien Helleman,Maurice P.H.M. Jansen,Kirsten Ruigrok-Ritstier,Iris L. van Staveren,Maxime P. Look,Marion E. Meijer‐van Gelder,Anieta M. Sieuwerts,Jan G.M. Klijn,Stefan Sleijfer,John A. Foekens,Els M.J.J. Berns	142
4	Subtypes of Breast Cancer Show Preferential Site of Relapsebreakdown → 2008 ·Cancer Research ·Marcel Smid,Yixin Wang,Yi Zhang,Anieta M. Sieuwerts,Jack X. Yu,Jan G.M. Klijn,John A. Foekens,John W.M. Martens	622
5	International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers 2008 ·International Journal of Cancer ·Kelly Metcalfe,Daphna Birenbaum‐Carmeli,Jan Lubiński,Jacek Gronwald,Henry T. Lynch,Pål Møller,Parviz Ghadirian,William D. Foulkes,Jan G.M. Klijn,Eitan Friedman,Charmaine Kim‐Sing,Peter Ainsworth,Barry P. Rosen,Susan M. Domchek,Teresa Wagner,Nadine Tung,Siranoush Manoukian,Fergus J. Couch,Ping Sun,Steven A. Narod	261
6	Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study 2007 ·Breast Cancer Research ·Annegien Broeks,Linde M. Braaf,Angelina Huseinovic,(unknown),Jos Urbanus,Frans B.L. Hogervorst,Marjanka K. Schmidt,Jan G.M. Klijn,Nicola S. Russell,Flora E. van Leeuwen,Laura van ‘t Veer	62
7	Concentrations of TIMP1 mRNA Splice Variants and TIMP-1 Protein Are Differentially Associated with Prognosis in Primary Breast Cancer 2007 ·Clinical Chemistry ·Anieta M. Sieuwerts,Pernille A. Usher,Marion E. Meijer‐van Gelder,Mieke Timmermans,John W.M. Martens,Nils Brünner,Jan G.M. Klijn,Hanne Offenberg,John A. Foekens	31
8	Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study 2006 ·International Journal of Radiation OncologyBiologyPhysics ·Maartje J. Hooning,Berthe M.P. Aleman,(unknown),Marianne A. Kuenen,Jan G.M. Klijn,Flora E. van Leeuwen	166
9	Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress 2006 ·Patient Education and Counseling ·Iris van Oostrom,Hanne Meijers‐Heijboer,Hugo J. Duivenvoorden,Annette Bröcker‐Vriends,Christi J. van Asperen,Rolf H. Sijmons,Caroline Seynaeve,Arthur R. Van Gool,Jan G.M. Klijn,Aad Tibben	46
10	Association of DNA Methylation of Phosphoserine Aminotransferase with Response to Endocrine Therapy in Patients with Recurrent Breast Cancer 2005 ·Cancer Research ·John W.M. Martens,Inko Nimmrich,Thomas Koenig,Maxime P. Look,Nadia Harbeck,Fabian Model,(unknown),Joan Bolt‐de Vries,Anieta M. Sieuwerts,Henk Portengen,Marion E. Meijer‐van Gelder,Christian Piepenbrock,Alexander Olek,Heinz Höfler,Marion Kiechle,Jan G.M. Klijn,Manfred Schmitt,Sabine Maier,John A. Foekens	102
11	Efficacy of Magnetic Resonance Imaging and Mammography for Breast Cancer Screening in Women With a Familial or Genetic Predisposition 2005 ·Obstetrical & Gynecological Survey ·Mieke Kriege,Cecile T.M. Brekelmans,C. Boetes,(unknown),Harmine M. Zonderland,Inge Marie Obdeijn,Radu A. Manoliu,Theo M. de Kok,Hans Peterse,(unknown),Sara Müller,Sybren Meijer,Jan C. Oosterwijk,L.V.A.M. Beex,Rob A.�E.�M. Tollenaar,Harry J. de Koning,(unknown),Jan G.M. Klijn	8
12	Hereditary breast cancer growth rates and its impact on screening policy 2005 ·European Journal of Cancer ·Madeleine M.A. Tilanus‐Linthorst,Mieke Kriege,C. Boetes,Wim C.J. Hop,Inge-Marie Obdeijn,Jan C. Oosterwijk,Hans Peterse,Harmine M. Zonderland,Sybren Meijer,Alexander M.M. Eggermont,Harry J. de Koning,Jan G.M. Klijn,Cecile T.M. Brekelmans	58
13	Are *ATM* Mutations 7271T→G and IVS10-6T→G Really High-Risk Breast Cancer-Susceptibility Alleles? 2004 ·Cancer Research ·Csilla I. Szabo,Mieke Schutte,Annegien Broeks,Jeanine J. Houwing‐Duistermaat,Yvonne R. Thorstenson,Francine Durocher,Rogier A. Oldenburg,Marijke Wasielewski,Fabrice Odefrey,Deborah J. Thompson,Arno Floore,Jaco Kraan,Jan G.M. Klijn,Ans M.W. van den Ouweland,(unknown),Teresa Wagner,Peter Devilee,Jacques Simard,Laura van ‘t Veer,David E. Goldgar,Hanne Meijers‐Heijboer	43
14	Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predispositionbreakdown → 2004 ·New England Journal of Medicine ·Mieke Kriege,Cecile T.M. Brekelmans,C. Boetes,(unknown),Harmine M. Zonderland,Inge Marie Obdeijn,Radu A. Manoliu,Theo M. de Kok,Hans Peterse,Madeleine M.A. Tilanus‐Linthorst,Sara Müller,Sybren Meijer,Jan C. Oosterwijk,L.V.A.M. Beex,Rob A.�E.�M. Tollenaar,Harry J. de Koning,Emiel J. Rutgers,Jan G.M. Klijn	1211
15	Breast Cancer after Prophylactic Bilateral Mastectomy in Women with aBRCA1orBRCA2Mutationbreakdown → 2001 ·New England Journal of Medicine ·(unknown),Bert van Geel,(unknown),Sonja C. Henzen‐Logmans,Caroline Seynaeve,Marian B. E. Menke‐Pluymers,Carina C. M. Bartels,Leon C. Verhoog,Ans M.W. van den Ouweland,Martinus F. Niermeijer,Cecile T.M. Brekelmans,Jan G.M. Klijn	658
16	Differential regulation of breast tumor cell proliferation by stromal fibroblasts of various breast tissue sources 1996 ·International Journal of Cancer ·Kees E. P. van Roozendaal,Jan G.M. Klijn,B van Ooijen,(unknown),Alexander M.M. Eggermont,Sonja C. Henzen‐Logmans,John A. Foekens	53
17	Rapid detection of BRCA1 mutations by the protein truncation test 1995 ·Nature Genetics ·Frans B.L. Hogervorst,(unknown),(unknown),Margreethe van Vliet,(unknown),Renske Olmer,Egbert Bakker,Jan G.M. Klijn,Hans F. A. Vasen,(unknown),Fred H. Menko,Cees J. Cornelisse,Johan T. den Dunnen,Peter Devilee,Gert‐Jan B. van Ommen	253
18	Prognostic factors in human primary breast cancer: Comparison of c-myc and HER2/neu amplification 1992 ·The Journal of Steroid Biochemistry and Molecular Biology ·E. Berns,John A. Foekens,Wim L.J. van Putten,Iris L. van Staveren,Henk Portengen,(unknown),Jan G.M. Klijn	41
19	Hormone secretion in alcohol-induced pseudo-Cushing's syndrome. Differential diagnosis with Cushing disease. 1979 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Steven W. J. Lamberts,Jan G.M. Klijn,Frank H. de Jong,J.C. Birkenhäger	57
20	The Incidence of Complications During Pregnancy after Treatment of Hyperprolactinemia with Bromocriptine in Patients with Radiologically Evident Pituitary Tumors 1979 ·Fertility and Sterility ·Steven W. J. Lamberts,Jan G.M. Klijn,(unknown),Ram B. Singh,S Stefanko,J.C. Birkenhäger	51

About Jan G.M. Klijn

Jan G.M. Klijn is a scholar working on Cancer Research, Genetics and Oncology, having authored 148 papers that have together received 16.8k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (56 papers), Breast Cancer Treatment Studies (23 papers) and Cancer Genomics and Diagnostics (19 papers). The work is most often cited by research in Cancer Research (6.0k citations), Oncology (6.1k citations) and Genetics (5.8k citations). Jan G.M. Klijn has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include John A. Foekens, Anieta M. Sieuwerts, Maxime P. Look, Els M.J.J. Berns, Yixin Wang, Marion E. Meijer‐van Gelder, Jack X. Yu, Yi Zhang, Cecile T.M. Brekelmans and John W.M. Martens. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact